TWD 77.8
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 364.47 Million TWD | 33.61% |
2022 | 272.79 Million TWD | 18.05% |
2021 | 231.09 Million TWD | -12.09% |
2020 | 262.87 Million TWD | 7.43% |
2019 | 244.7 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 469.81 Million TWD | 28.9% |
2024 Q2 | 232.62 Million TWD | -50.49% |
2023 Q3 | 257.68 Million TWD | -7.52% |
2023 FY | 364.47 Million TWD | 33.61% |
2023 Q1 | 369.55 Million TWD | 35.47% |
2023 Q2 | 278.64 Million TWD | -24.6% |
2023 Q4 | 364.47 Million TWD | 41.44% |
2022 Q4 | 272.79 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Bio Preventive Medicine Corp. | 124.72 Million TWD | -192.214% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 1.047% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -4471.952% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | -10.962% |
NaviFUS Corp. | 53.4 Million TWD | -582.527% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -204.085% |
TaiRx, Inc. | 60.62 Million TWD | -501.198% |
Sinew Pharma Inc. | 39.71 Million TWD | -817.752% |
Lin BioScience, Inc. | 167.73 Million TWD | -117.299% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -5407.344% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -60.073% |
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -5111.267% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 37.534% |
AP Biosciences Inc | 106.65 Million TWD | -241.75% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 50.275% |
RBC Bioscience Corporation | 513.08 Million TWD | 28.963% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 62.604% |
EirGenix Inc. | 1.14 Billion TWD | 68.171% |
Enimmune corporation | 173.46 Million TWD | -110.117% |
Lukas Biomedical Inc. | 161.05 Million TWD | -126.3% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -764.548% |
3D Global Biotech Inc. | 30.68 Million TWD | -1087.953% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 72.551% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 72.455% |
TCI GENE Inc. | 155.54 Million TWD | -134.317% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -1617.121% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 57.934% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -3829.237% |
Feng Chi Biotech Corp. | 63.03 Million TWD | -478.221% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | -84.572% |
TWi Biotechnology, Inc. | 55.81 Million TWD | -553.031% |
Neith Corporation | 17.43 Million TWD | -1990.724% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 28.874% |
VBI | 21.25 Million TWD | -1615.1% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -56.455% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | -16.184% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -1467.302% |
CHO Pharma, Inc. | 110.83 Million TWD | -228.854% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -527.985% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -1328.869% |
Visgeneer Inc. | 185.6 Million TWD | -96.372% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -225.48% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 24.302% |
Sagittarius Life Science Corp | 137.82 Million TWD | -164.45% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -288.924% |
GlycoNex Incorporation | 276.39 Million TWD | -31.866% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 89.675% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | -85.967% |
PharmaEngine, Inc. | 91 Million TWD | -300.497% |
Intech Biopharm Corporation | 1.54 Billion TWD | 76.382% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 29.18% |
BiOptic Inc. | 170.56 Million TWD | -113.69% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -228.534% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -689.336% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -461.709% |
OBI Pharma, Inc. | 650.44 Million TWD | 43.965% |
Savior Lifetec Corporation | 457.95 Million TWD | 20.413% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -1259.326% |
Level Biotechnology Inc. | 273.2 Million TWD | -33.409% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 83.773% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | 6.739% |
Acepodia, Inc. | 384.47 Million TWD | 5.201% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -326.024% |